{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:46:20Z","timestamp":1792727180470,"version":"4.5.0"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,5]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Bacille Calmette\u2013Gu\u00e9rin (BCG) vaccine is designed to provide protection against tuberculosis (TB). However, numerous epidemiological, clinical, and immunological studies have shown that BCG vaccination affects neonatal and infant mortality, which may be related to the reduction of TB-unrelated infections and diseases by BCG vaccine. We aimed to discuss the off-target effects of BCG vaccine on un-TB infections and diseases, as well as the potential mechanism and influencing factors. Literature was retrieved mainly from PubMed using medical subject headings \"BCG, variations, and non-specific, heterologous or off-target\". Studies have showed that BCG vaccination can prevent various heterologous infections, including respiratory tract infections, leprosy, and malaria, treat viral infections including human papillomavirus and herpes simplex virus infection as immunotherapy, and improve the immune responses as vaccine adjuvant. Besides, BCG vaccine can reduce the recurrence rate of non-muscle-invasive bladder cancer, and may provide protection against autoimmune diseases. These off-target effects of BCG vaccine are thought to be achieved by modulating heterologous lymphocyte responses or inducing trained immunity, which were found to be sex-differentiated and affected by the BCG vaccine strains, sequence or time of vaccination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002890","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T04:05:34Z","timestamp":1702526734000},"page":"2065-2074","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Research progress in the off-target effects of Bacille Calmette\u2013Gu\u00e9rin vaccine"],"prefix":"10.1097","volume":"137","author":[{"given":"Yanfei","family":"Wu","sequence":"first","affiliation":[{"name":"School of Public Health, Southeast University, Nanjing, Jiangsu 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Public Health, Southeast University, Nanjing, Jiangsu 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[{"name":"Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210009, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Lu","sequence":"additional","affiliation":[{"name":"IB Course Center of High School Affiliated to Shanghai Jiaotong University, Shanghai 200439, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengcai","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, Southeast University, Nanjing, Jiangsu 210009, China"},{"name":"Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210009, China"},{"name":"NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu 210009, China"},{"name":"Institute of Global Public Health and Emergency Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Li","sequence":"additional","affiliation":[{"name":"School of Public Health, Southeast University, Nanjing, Jiangsu 210009, China"},{"name":"Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 210009, China"},{"name":"NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu 210009, China"},{"name":"Institute of Global Public Health and Emergency Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148291","article-title":"BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases","volume":"131","author":"Singh","year":"2021","journal-title":"J Clin Invest"},{"key":"R3-20250602","first-page":"1481","article-title":"Preventive Vaccination Against Tuberculosis with BCG","volume":"24","author":"Calmette","year":"1931","journal-title":"Proc R Soc Med"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"Shann","year":"2013","journal-title":"Clin Ther"},{"key":"R5-20250602","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"Bmj"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/cix525","article-title":"Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial","volume":"65","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1473-3099(20)30653-8","article-title":"BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial","volume":"21","author":"Prentice","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R8-20250602","first-page":"57","article-title":"Bacille Calmette Gu\u00e9rin (BCG) and new TB vaccines: Specific, cross-mycobacterial and off-target effects","volume":"36","author":"Fritschi","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2013-2218","article-title":"Acute lower respiratory infection among Bacille Calmette-Gu\u00e9rin (BCG)-vaccinated children","volume":"133","author":"Hollm-Delgado","year":"2014","journal-title":"Pediatrics"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R12-20250602","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: Randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(06)70412-1","article-title":"The role of BCG in prevention of leprosy: a meta-analysis","volume":"6","author":"Setia","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2018.03.009","article-title":"BCG vaccine: WHO position paper, February 2018-Recommendations","volume":"36","author":"World Health","year":"2018","journal-title":"Vaccine"},{"key":"R16-20250602","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001862","article-title":"BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa","volume":"4","author":"Berendsen","year":"2019","journal-title":"BMJ Glob Health"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.urology.2004.09.025","article-title":"Application of viable bacille Calmette-Gu\u00e9rin topically as a potential therapeutic modality in condylomata acuminata: a placebo-controlled study","volume":"65","author":"Metawea","year":"2005","journal-title":"Urology"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4103\/0378-6323.193623","article-title":"Immunotherapy in viral warts with intradermal Bacillus Calmette-Guerin vaccine versus intradermal tuberculin purified protein derivative: A double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India","volume":"83","author":"Podder","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R19-20250602","first-page":"589","article-title":"Bacille Calmette-Guerin immunotherapy of viral warts","volume":"29","author":"Sharquie","year":"2008","journal-title":"Saudi Med J"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1525-1470.2012.01848.x","article-title":"Treatment of common and plane warts in children with topical viable Bacillus Calmette-Guerin","volume":"30","author":"Salem","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R21-20250602","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14549","article-title":"Bacillus Calmette-Guerin polysaccharide nucleic acid vs Bacillus Calmette-Guerin vaccine in the treatment of warts: A comparative, double-blind, controlled study","volume":"34","author":"Ebrahim","year":"2021","journal-title":"Dermatol Ther"},{"key":"R22-20250602","first-page":"200","article-title":"[Nonspecific immune stimulation with BCG in Herpes simplex recidivans. Follow-up 5 to 10 years after BCG vaccination]","volume":"104","author":"Hippmann","year":"1992","journal-title":"Wien Klin Wochenschr"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2151","article-title":"Does bacillus Calmette-Gu\u00e9rin vaccine prevent herpes simplex virus recurrences? A systematic review","volume":"31","author":"Pittet","year":"2021","journal-title":"Rev Med Virol"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4049\/jimmunol.168.2.919","article-title":"Influence of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin on antibody and cytokine responses to human neonatal vaccination","volume":"168","author":"Ota","year":"2002","journal-title":"J Immunol"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2019.03.016","article-title":"The influence of neonatal Bacille Calmette-Gu\u00e9rin (BCG) immunisation on heterologous vaccine responses in infants","volume":"37","author":"Zimmermann","year":"2019","journal-title":"Vaccine"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2013.03.059","article-title":"Non-specific effect of Bacille Calmette-Gu\u00e9rin vaccine on the immune response to routine immunisations","volume":"31","author":"Ritz","year":"2013","journal-title":"Vaccine"},{"key":"R28-20250602","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"R30-20250602","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","article-title":"Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Gu\u00e9rin, and bacillus Calmette-Gu\u00e9rin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder","volume":"57","author":"Sylvester","year":"2010","journal-title":"Eur Urol"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2009.04.009","article-title":"Long-term efficacy of maintenance bacillus Calmette-Gu\u00e9rin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up","volume":"56","author":"J\u00e4rvinen","year":"2009","journal-title":"Eur Urol"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eururo.2009.09.038","article-title":"Bacillus Calmette-Gu\u00e9rin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study","volume":"57","author":"Duchek","year":"2010","journal-title":"Eur Urol"},{"key":"R33-20250602","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.eururo.2014.09.026","article-title":"Sequential combination of mitomycin C plus bacillus Calmette-Gu\u00e9rin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: final outcome of CUETO 93009, a randomized prospective trial","volume":"67","author":"Solsona","year":"2015","journal-title":"Eur Urol"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2016.03.034","article-title":"Intravesical Bacillus Calmette-Gu\u00e9rin Versus Combination of Epirubicin and Interferon-\u03b12a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study","volume":"70","author":"Marttila","year":"2016","journal-title":"Eur Urol"},{"key":"R35-20250602","first-page":"Cd012112","article-title":"Intravesical Bacillus Calmette-Gu\u00e9rin with interferon-alpha versus intravesical Bacillus Calmette-Gu\u00e9rin for treating non-muscle-invasive bladder cancer","volume":"3","author":"Shepherd","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R36-20250602","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40425-017-0271-0","article-title":"Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma","volume":"5","author":"Kamat","year":"2017","journal-title":"J Immunother Cancer"},{"key":"R37-20250602","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"R38-20250602","first-page":"420","article-title":"Combined effects of neonatal Bacillus Calmette-Guerin vaccination and respiratory syncytial infection on experimental asthma in mice (in Chinese)","volume":"44","author":"Li","year":"2006","journal-title":"Chin J Pedi"},{"key":"R39-20250602","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1081-1206(10)61890-X","article-title":"Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial","volume":"88","author":"Choi","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"NPJ Vaccines"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","article-title":"Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS","volume":"82","author":"Ristori","year":"2014","journal-title":"Neurology"},{"key":"R42-20250602","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R43-20250602","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"R44-20250602","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"key":"R45-20250602","doi-asserted-by":"crossref","first-page":"622995","DOI":"10.3389\/fimmu.2021.622995","article-title":"Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG","volume":"12","author":"Esteso","year":"2021","journal-title":"Front Immunol"},{"key":"R46-20250602","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1293212","article-title":"Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes","volume":"6","author":"Garc\u00eda-Cuesta","year":"2017","journal-title":"Oncoimmunology"},{"key":"R47-20250602","first-page":"284","article-title":"NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation","volume":"6","author":"Garc\u00eda-Cuesta","year":"2015","journal-title":"Front Immunol"},{"key":"R48-20250602","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urolonc.2020.09.031","article-title":"Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer","volume":"39","author":"Sfakianos","year":"2021","journal-title":"Urol Oncol"},{"key":"R49-20250602","first-page":"1469","article-title":"Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer","volume":"17","author":"Sonoda","year":"2007","journal-title":"Oncol Rep"},{"key":"R50-20250602","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/1744666X.2014.909286","article-title":"The interplay between bacillus Calmette-Gu\u00e9rin and Treg cells and its role to prevent or cure inflammatory diseases","volume":"10","author":"Lagranderie","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"R51-20250602","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1398-9995.2012.02880.x","article-title":"Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling","volume":"67","author":"Yang","year":"2012","journal-title":"Allergy"},{"key":"R52-20250602","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1080\/21645515.2017.1313366","article-title":"Bacillus Calmette-Guerin alleviates airway inflammation and remodeling by preventing TGF-\u03b2(1) induced epithelial-mesenchymal transition","volume":"13","author":"Tian","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"R53-20250602","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/eci.12132","article-title":"Training innate immunity: the changing concept of immunological memory in innate host defence","volume":"43","author":"Netea","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"R54-20250602","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55-20250602","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment","volume":"28","author":"B., de Bree","year":"2020","journal-title":"Cell Host Microbe"},{"key":"R56-20250602","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic Pathways in BCG-Induced Trained Immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"key":"R57-20250602","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R58-20250602","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"R59-20250602","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"van Puffelen","year":"2020","journal-title":"Nat Rev Urol"},{"key":"R60-20250602","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathog"},{"key":"R61-20250602","doi-asserted-by":"crossref","first-page":"E412","DOI":"10.5489\/cuaj.7066","article-title":"Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"15","author":"Graham","year":"2021","journal-title":"Can Urol Assoc J"},{"key":"R62-20250602","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/joim.13050","article-title":"Benefits of BCG-induced metabolic switch from oxidative phosphorylation to aerobic glycolysis in autoimmune and nervous system diseases","volume":"288","author":"Faustman","year":"2020","journal-title":"J Intern Med"},{"key":"R63-20250602","doi-asserted-by":"crossref","first-page":"868343","DOI":"10.3389\/fimmu.2022.868343","article-title":"Trained Immunity Contribution to Autoimmune and Inflammatory Disorders","volume":"13","author":"Funes","year":"2022","journal-title":"Front Immunol"},{"key":"R64-20250602","doi-asserted-by":"crossref","first-page":"14933","DOI":"10.1038\/s41598-021-94529-2","article-title":"BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation","volume":"11","author":"Keefe","year":"2021","journal-title":"Sci Rep"},{"key":"R65-20250602","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"R66-20250602","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2009.02.006","article-title":"The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1","volume":"30","author":"Thomas","year":"2009","journal-title":"Immunity"},{"key":"R67-20250602","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.immuni.2009.02.005","article-title":"The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA","volume":"30","author":"Allen","year":"2009","journal-title":"Immunity"},{"key":"R68-20250602","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.3389\/fimmu.2019.02307","article-title":"Bacille Calmette-Gu\u00e9rin Vaccine Strain Modulates the Ontogeny of Both Mycobacterial-Specific and Heterologous T Cell Immunity to Vaccination in Infants","volume":"10","author":"Kiravu","year":"2019","journal-title":"Front Immunol"},{"key":"R69-20250602","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ni.2961","article-title":"Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges","volume":"15","author":"Aaby","year":"2014","journal-title":"Nat Immunol"},{"key":"R70-20250602","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/infdis\/jit570","article-title":"Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants","volume":"209","author":"Lutwama","year":"2014","journal-title":"J Infect Dis"},{"key":"R71-20250602","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/infdis\/jix612","article-title":"Rapid Protective Effects of Early BCG on Neonatal Mortality Among Low Birth Weight Boys: Observations From Randomized Trials","volume":"217","author":"Biering-S\u00f8rensen","year":"2018","journal-title":"J Infect Dis"},{"key":"R72-20250602","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.vaccine.2022.01.005","article-title":"Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner","volume":"40","author":"Pittet","year":"2022","journal-title":"Vaccine"},{"key":"R73-20250602","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1172\/JCI133935","article-title":"BCG vaccination in humans inhibits systemic inflammation in a sex-dependent manner","volume":"130","author":"Koeken","year":"2020","journal-title":"J Clin Invest"},{"key":"R74-20250602","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10096-020-03813-y","article-title":"Differential effects of BCG vaccine on immune responses induced by vi polysaccharide typhoid fever vaccination: an explorative randomized trial","volume":"39","author":"Blok","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R75-20250602","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2017.07.012","article-title":"Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then DTP. A Re-analysis of Demographic Surveillance Data From Rural Bangladesh","volume":"22","author":"Aaby","year":"2017","journal-title":"EBioMedicine"},{"key":"R76-20250602","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/jpids\/piy029","article-title":"BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial","volume":"8","author":"Stensballe","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R77-20250602","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination at birth: Effects on early childhood infections, growth, and development","volume":"63","author":"Kj\u00e6rgaard","year":"2016","journal-title":"Dan Med J"},{"key":"R78-20250602","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jaci.2016.12.990","article-title":"Neonatal BCG vaccination has no effect on recurrent wheeze in the first year of life: A randomized clinical trial","volume":"140","author":"Th\u00f8stesen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R79-20250602","doi-asserted-by":"crossref","DOI":"10.1111\/ene.15290","article-title":"Bacillus Calmette-Guerin vaccination and multiple sclerosis: A population-based birth cohort study in Quebec, Canada","author":"Corsenac","year":"2022","journal-title":"Eur J Neurol"},{"key":"R80-20250602","doi-asserted-by":"crossref","first-page":"106893","DOI":"10.1016\/j.ypmed.2021.106893","article-title":"Association between Bacillus Calmette-Guerin vaccination and type 1 diabetes in adolescence: A population-based birth cohort study in Quebec, Canada","volume":"154","author":"Corsenac","year":"2022","journal-title":"Prev Med"},{"key":"R81-20250602","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/cid\/ciz1080","article-title":"Early Vaccination With Bacille Calmette-Gu\u00e9rin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial","volume":"71","author":"Schaltz-Buchholzer","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R82-20250602","doi-asserted-by":"crossref","first-page":"873067","DOI":"10.3389\/fimmu.2022.873067","article-title":"ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk","volume":"13","author":"Tsilika","year":"2022","journal-title":"Front Immunol"},{"key":"R83-20250602","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1093\/cid\/ciac182","article-title":"Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic","volume":"75","author":"Moorlag","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R84-20250602","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2023.02.014","article-title":"The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil","volume":"130","author":"Santos","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R85-20250602","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00356-23","article-title":"BCG Vaccination of Health Care Workers Does Not Reduce SARS-CoV-2 Infections nor Infection Severity or Duration: a Randomized Placebo-Controlled Trial","volume":"14","author":"Claus","year":"2023","journal-title":"mBio"},{"key":"R86-20250602","doi-asserted-by":"crossref","first-page":"101414","DOI":"10.1016\/j.eclinm.2022.101414","article-title":"Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial","volume":"48","author":"Upton","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R87-20250602","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","article-title":"Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers","volume":"388","author":"Pittet","year":"2023","journal-title":"N Engl J Med"},{"key":"R88-20250602","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.3390\/cells10113179","article-title":"Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2","volume":"10","author":"Ramos-Martinez","year":"2021","journal-title":"Cells"},{"key":"R89-20250602","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41541-021-00406-4","article-title":"A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection","volume":"6","author":"Counoupas","year":"2021","journal-title":"NPJ Vaccines"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:03:38Z","timestamp":1748891018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":87,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002890","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"2023-07-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}